These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

75 related articles for article (PubMed ID: 7853200)

  • 1. A selective type V phosphodiesterase inhibitor, E4021, dilates porcine large coronary artery.
    Saeki T; Adachi H; Takase Y; Yoshitake S; Souda S; Saito I
    J Pharmacol Exp Ther; 1995 Feb; 272(2):825-31. PubMed ID: 7853200
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Potency and mechanism of action of E4021, a type 5 phosphodiesterase isozyme-selective inhibitor, on the photoreceptor phosphodiesterase depend on the state of activation of the enzyme.
    D'Amours MR; Granovsky AE; Artemyev NO; Cote RH
    Mol Pharmacol; 1999 Mar; 55(3):508-14. PubMed ID: 10051534
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The cGMP-specific phosphodiesterase inhibitor E4021 dilates the pulmonary circulation.
    Dukarm RC; Russell JA; Morin FC; Perry BJ; Steinhorn RH
    Am J Respir Crit Care Med; 1999 Sep; 160(3):858-65. PubMed ID: 10471609
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Coronary artery diameter increase induced by a phosphodiesterase 5 inhibitor, E4021, in conscious pigs.
    Adachi H; Nishino M
    Jpn J Pharmacol; 1998 May; 77(1):99-102. PubMed ID: 9639065
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of a novel, selective and potent phosphodiesterase type V inhibitor, E4021, on myocardial ischemia in guinea pigs.
    Kodama K; Adachi H; Mori N; Saito I
    Eur J Pharmacol; 1994 Sep; 263(1-2):93-9. PubMed ID: 7821368
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Isoenzymes of cyclic nucleotide phosphodiesterase in the human aorta: characterization and the effects of E4021.
    Miyahara M; Ito M; Itoh H; Shiraishi T; Isaka N; Konishi T; Nakano T
    Eur J Pharmacol; 1995 Sep; 284(1-2):25-33. PubMed ID: 8549633
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibition of platelet adhesion and aggregation by E4021, a type V phosphodiesterase inhibitor, in guinea pigs.
    Chiu PJ; Vemulapalli S; Chintala M; Kurowski S; Tetzloff GG; Brown AD; Sybertz EJ
    Naunyn Schmiedebergs Arch Pharmacol; 1997 Apr; 355(4):463-9. PubMed ID: 9109362
    [TBL] [Abstract][Full Text] [Related]  

  • 8. 4-Benzylamino-1-chloro-6-substituted phthalazines: synthesis and inhibitory activity toward phosphodiesterase 5.
    Watanabe N; Kabasawa Y; Takase Y; Matsukura M; Miyazaki K; Ishihara H; Kodama K; Adachi H
    J Med Chem; 1998 Aug; 41(18):3367-72. PubMed ID: 9719589
    [TBL] [Abstract][Full Text] [Related]  

  • 9. E4021, a selective phosphodiesterase 5 inhibitor, potentiates the vasodilator effect of inhaled nitric oxide in isolated perfused rat lungs.
    Ohnishi M; Oka M; Muramatsu M; Sato K; Kira S; Fukuchi Y
    J Cardiovasc Pharmacol; 1999 Apr; 33(4):619-24. PubMed ID: 10218733
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification, characterization and functional role of phosphodiesterase isozymes in human airway smooth muscle.
    Torphy TJ; Undem BJ; Cieslinski LB; Luttmann MA; Reeves ML; Hay DW
    J Pharmacol Exp Ther; 1993 Jun; 265(3):1213-23. PubMed ID: 8389856
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of various phosphodiesterase-inhibitors, forskolin, and sodium nitroprusside on porcine detrusor smooth muscle tonic responses to muscarinergic stimulation and cyclic nucleotide levels in vitro.
    Truss MC; Uckert S; Stief CG; Kuczyk M; Schulz-Knappe P; Forssmann WG; Jonas U
    Neurourol Urodyn; 1996; 15(1):59-70. PubMed ID: 8696357
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Diphenylamine-2-carboxylic acid potentiates the cyclic nucleotides-mediated relaxation of porcine coronary artery: possible involvement of the inhibitory effect on the efflux of cyclic nucleotides.
    Nakahara T; Mitani A; Saito M; Sakamoto K; Ishii K
    Vascul Pharmacol; 2004 Feb; 41(1):21-5. PubMed ID: 15135328
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification, characterization, and functional role of phosphodiesterase type IV in cerebral vessels: effects of selective phosphodiesterase inhibitors.
    Willette RN; Shiloh AO; Sauermelch CF; Sulpizio A; Michell MP; Cieslinski LB; Torphy TJ; Ohlstein EH
    J Cereb Blood Flow Metab; 1997 Feb; 17(2):210-9. PubMed ID: 9040501
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Potentiation of erectile response and cAMP accumulation by combination of prostaglandin E1 and rolipram, a selective inhibitor of the type 4 phosphodiesterase (PDE 4).
    Bivalacqua TJ; Champion HC; Rajasekaran M; Sikka SC; Kadowitz PJ; Doherty PC; Hellstrom WJ
    J Urol; 1999 Nov; 162(5):1848-55. PubMed ID: 10524946
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibition of cyclic 3'-5'-guanosine monophosphate-specific phosphodiesterase selectively vasodilates the pulmonary circulation in chronically hypoxic rats.
    Cohen AH; Hanson K; Morris K; Fouty B; McMurty IF; Clarke W; Rodman DM
    J Clin Invest; 1996 Jan; 97(1):172-9. PubMed ID: 8550830
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The vasorelaxant effect of caffeic acid phenethyl ester on porcine coronary artery ring segments.
    Long Y; Han M; Chen J; Tian XZ; Chen Q; Wang R
    Vascul Pharmacol; 2009; 51(2-3):78-83. PubMed ID: 19345746
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Modulation of rat thymocyte proliferative response through the inhibition of different cyclic nucleotide phosphodiesterase isoforms by means of selective inhibitors and cGMP-elevating agents.
    Marcoz P; Prigent AF; Lagarde M; Nemoz G
    Mol Pharmacol; 1993 Nov; 44(5):1027-35. PubMed ID: 8246905
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Multiple cyclic nucleotide phosphodiesterases in human trabecular meshwork cells.
    Zhou L; Thompson WJ; Potter DE
    Invest Ophthalmol Vis Sci; 1999 Jul; 40(8):1745-52. PubMed ID: 10393044
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characterization of the isoenzymes of cyclic nucleotide phosphodiesterase in human platelets and the effects of E4021.
    Ito M; Nishikawa M; Fujioka M; Miyahara M; Isaka N; Shiku H; Nakano T
    Cell Signal; 1996 Dec; 8(8):575-81. PubMed ID: 9115850
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Relaxing effects of cyclic GMP and cyclic AMP-enhancing agents on the long-lasting contraction to endothelin-1 in the porcine coronary artery.
    Lillestłl IK; Helle KB; Aardal S
    Scand J Clin Lab Invest; 1998 Dec; 58(8):625-34. PubMed ID: 10088199
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.